DK0584368T3 - Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof - Google Patents
Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistofInfo
- Publication number
- DK0584368T3 DK0584368T3 DK93904304T DK93904304T DK0584368T3 DK 0584368 T3 DK0584368 T3 DK 0584368T3 DK 93904304 T DK93904304 T DK 93904304T DK 93904304 T DK93904304 T DK 93904304T DK 0584368 T3 DK0584368 T3 DK 0584368T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitor
- antibody
- cell adhesion
- metastasis
- preparing
- Prior art date
Links
- 230000021164 cell adhesion Effects 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 239000002257 antimetastatic agent Substances 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 abstract 1
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5955192 | 1992-02-14 | ||
PCT/JP1993/000182 WO1993016193A1 (en) | 1992-02-14 | 1993-02-12 | Cell adhesion inhibiting antibody and cell adhesion inhibitor containing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0584368T3 true DK0584368T3 (da) | 2002-06-17 |
Family
ID=13116505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93904304T DK0584368T3 (da) | 1992-02-14 | 1993-02-12 | Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof |
Country Status (9)
Country | Link |
---|---|
US (1) | US5648078A (da) |
EP (1) | EP0584368B1 (da) |
JP (1) | JP3483556B2 (da) |
AT (1) | ATE217909T1 (da) |
DE (1) | DE69331942T2 (da) |
DK (1) | DK0584368T3 (da) |
ES (1) | ES2177540T3 (da) |
PT (1) | PT584368E (da) |
WO (1) | WO1993016193A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004031238A2 (en) * | 2002-10-03 | 2004-04-15 | Mcgill Univeristy | Antibodies and cyclic peptides which bind cea (carcinoembryonic antigen) and their use as cancer therapeutics |
JP2002503462A (ja) * | 1998-02-12 | 2002-02-05 | マクギル ユニバーシティ | Cea/ncaに基づいた癌分化療法 |
CA2798932C (en) | 2010-05-11 | 2023-04-04 | Governing Council Of The University Of Toronto | The n-domain of carcinoembryonic antigen and compositions, methods and uses thereof |
US9753036B2 (en) * | 2014-04-29 | 2017-09-05 | Edp Biotech Corporation | Methods and compositions for screening and detecting biomarkers |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4348376A (en) * | 1980-03-03 | 1982-09-07 | Goldenberg Milton David | Tumor localization and therapy with labeled anti-CEA antibody |
JPH0811075B2 (ja) * | 1982-06-30 | 1996-02-07 | 雄治 松岡 | 単クローン性抗cea抗体 |
JP2607492B2 (ja) * | 1987-01-14 | 1997-05-07 | サントリー株式会社 | ヒト癌胎児性抗原 |
GB8800078D0 (en) * | 1988-01-05 | 1988-02-10 | Ciba Geigy Ag | Novel antibodies |
GB9014932D0 (en) * | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
JPH05119037A (ja) * | 1991-08-08 | 1993-05-14 | Suntory Ltd | ヒト癌胎児性抗原の免疫測定法 |
-
1993
- 1993-02-12 DE DE69331942T patent/DE69331942T2/de not_active Expired - Fee Related
- 1993-02-12 PT PT93904304T patent/PT584368E/pt unknown
- 1993-02-12 ES ES93904304T patent/ES2177540T3/es not_active Expired - Lifetime
- 1993-02-12 US US08/129,195 patent/US5648078A/en not_active Expired - Fee Related
- 1993-02-12 DK DK93904304T patent/DK0584368T3/da active
- 1993-02-12 AT AT93904304T patent/ATE217909T1/de not_active IP Right Cessation
- 1993-02-12 WO PCT/JP1993/000182 patent/WO1993016193A1/ja active IP Right Grant
- 1993-02-12 EP EP93904304A patent/EP0584368B1/en not_active Expired - Lifetime
- 1993-02-12 JP JP51395293A patent/JP3483556B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PT584368E (pt) | 2002-10-31 |
ATE217909T1 (de) | 2002-06-15 |
ES2177540T3 (es) | 2002-12-16 |
EP0584368B1 (en) | 2002-05-22 |
EP0584368A4 (en) | 1996-07-03 |
WO1993016193A1 (en) | 1993-08-19 |
DE69331942T2 (de) | 2002-10-02 |
US5648078A (en) | 1997-07-15 |
EP0584368A1 (en) | 1994-03-02 |
DE69331942D1 (de) | 2002-06-27 |
JP3483556B2 (ja) | 2004-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT7924401A0 (it) | Procedimento per la purificazione e coltivazione sequenziale di cristalli di silicio. | |
GEPI20105119B (en) | Chimeric anti-cd20 antibody | |
ATE47711T1 (de) | Biologisch aktive verbindung mit anti-prolyl endopeptidasewirkung. | |
DE3581514D1 (de) | Film zur behandlung von halbleiterwaffeln. | |
NO177700C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, hydroksaminsyrebaserte kollagenaseinhibitorforbindelser, samt mellomprodukter til anvendelse i framgangsmåten | |
BG101966A (en) | Application of 1l-agonist for the treatment of lack of urine retention | |
IT1229181B (it) | Mezzi di trasporto per buste. | |
EP0982988A4 (en) | IN KEY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF "TIGHT JUNCTIONS" IN MAMMALS | |
DE69630955D1 (de) | Immortalisierung bzw. desimmortalisierung von zellen | |
ES2129487T3 (es) | Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion. | |
IT8220139A0 (it) | Procedimento di micro-incapsulamento, particolarmente di colture di cellule. | |
EP0396505A3 (en) | Monoclonal antibodies specific for an immunoglobulin isotype | |
DK0584368T3 (da) | Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof | |
NO850027L (no) | Overflateaktiv forbindelse og emulsjon inneholdende denne, samt anvendelse derav. | |
IT1231727B (it) | Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone. | |
DE59309740D1 (de) | Lyopilisierte, wirkstoffhaltige emulsion | |
NO875199L (no) | Renin-inhibitorer. | |
IT8722316A0 (it) | Confezione di prodotti chimici. | |
NO891713D0 (no) | Monoklonale antistoffer til vevplasminogenaktivator (t-pa) | |
IT1142141B (it) | Procedimento e substrato di fermentazione | |
FI941394A0 (fi) | Peptidejä,jotka kykenevät säätelemään akrosomireaktiota | |
IT8125461A0 (it) | Enzima terapeuticamente utile eprocedimento per la sua preparazione. | |
IT7926516A0 (it) | Ibrido della euforbia di colore salmone e procedimento per la sua moltiplicazione vegetativa. | |
IT8321507A0 (it) | Procedimento di preparazione fermentativa di l-leucina. | |
IT1127697B (it) | Cassa di valvola per aerosol |